Related Experiment Video
Updated: Jun 18, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectations
1Dallas Allergy Immunology, 7777 Forest Lane, Suite B-332, Dallas, TX 75230, USA.
Objective:
The availability of weekly subcutaneous infusions of subcutaneous immunoglobulin (SCIg) provides an additional therapeutic option for patients with primary immunodeficiency disease. With proper patient education, individuals can safely transition to SCIg therapy and experience minimal side effects.
Research Design:
Case reports.
Results:
A plan for successful implementation of SCIg therapy is presented. Case reports illustrate the how to manage the transition from IVIg to home infusion of SCIg. In Case 1, despite training, home infusion was complicated by infusion-site reactions, the most common adverse event. Troubleshooting by the medical staff identified improper administration of SCIg, a correctable cause of reactions. In Case 2, patient education enabled this woman to successfully transition to SCIg without adverse effects, and without the headache and fatigue she experienced with IVIg.
Conclusions:
Home infusion of SCIg can be successfully implemented with careful planning, patient/caregiver education, support, and follow-up.
Related Concept Videos
Hypersensitivity Reactions: Immune-Complex Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Hypersensitivity Reactions: Cytolytic Reactions
